Skip to main content
Equibles

UBS Group AG

Position in ASMB — Assembly Biosciences, Inc.

CIK 1610520 ZURICH, V8
Back to ASMB Full portfolio

Position in ASMB

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,148,828
+$1,138,727 QoQ
Shares Held
41,806
+11385.2% QoQ
Ownership
0.205%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#40
of 92 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ASMB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,801 across 560 Biotechnology names. ASMB ranks #257 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in ASMB

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,148,828 41,806
2026-03-31 $10,101 364
2025-12-31 $332,583 9,779
2025-09-30 $403,532 15,763
2025-06-30 $53,145 2,933
2025-03-31 $7,331 767
2024-12-31 $103,310 6,547
2024-09-30 $19,697 1,301
2024-06-30 $40,459 2,949
2024-03-31 $43,025 3,235
2023-12-31 $19,814 24,164
2023-03-31 $8,904 10,601
2022-12-31 $31,208 24,007
2022-09-30 $18,746 11,431
2022-06-30 $1,280 610
2022-03-31 $7,720 3,748
2021-12-31 $14,730 6,322
2021-09-30 $499,842 143,633
2021-06-30 $551,530 142,147
2021-03-31 $71,676 15,582
2020-12-31 $45,452 7,513
2020-09-30 $80,555 4,900
2020-06-30 $150,459 6,452
2020-03-31 $208,197 14,039